Editorial

モデルの実力を評価

Nature Biotechnology 33, 7 doi: 10.1038/nbt.3279

The time has come to systematically assess the pros and cons of different mouse models as predictors of patient responses to cancer therapies.

目次へ戻る

プライバシーマーク制度